Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Oxidative stress contributes to alopecia areata, suggesting antioxidant treatments might help.

No single treatment is clearly effective for central serous chorioretinopathy.

Atopic dermatitis increases the risk of some autoimmune diseases.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Platelet-Rich Plasma may improve skin health and reduce wrinkles, but more research is needed for standard treatment guidelines.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Many transgender men on testosterone therapy experience hair loss.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Prostaglandin analogs like Latanoprost might help grow hair on the scalp and body.

The Korean study confirmed that bariatric surgery is effective for weight loss in Asians.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

PRP shows promise for treating female hair loss but needs more research.

Androgen use may increase the risk of stroke, but more research is needed.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Certain gut bacteria may increase or decrease the risk of male pattern baldness.

Low-dose oral Minoxidil is an effective treatment for hair loss with minimal serious side effects.

Melatonin may help improve hair growth in people with certain types of hair loss.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.